Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Breast cancer.

S R Patel, C L Loprinzi

    Cancer Chemotherapy and Biological Response Modifiers
    |January 1, 1991
    PubMed
    Summary
    This summary is machine-generated.

    Research in breast cancer focuses on cure, with adjuvant therapy debated for early-stage patients. Advances in molecular understanding may offer future prevention and treatment strategies for this complex disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Acute maternal hyperoxygenation protocol: consensus opinion from the Fetal Heart Society.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024
    Same author

    The tooth survival of non-surgical root-filled posterior teeth and the associated prognostic tooth-related factors: A systematic review and meta-analysis.

    International endodontic journal·2024
    Same author

    Kielin/Chordin-Like Protein-A Novel Pathway to Prevent Renal Fibrosis?: Kielin/Chordin-Like Protein, a Novel Enhancer of BMP Signaling, Attenuates Renal Fibrotic Disease. Nat Med 11: 387-393, 2005.

    Journal of the American Society of Nephrology : JASN·2023
    Same author

    Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA).

    The Journal of infection·2022
    Same author

    Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    Mid-cervical interneuron networks following high cervical spinal cord injury.

    Respiratory physiology & neurobiology·2019
    Same journal

    Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Human tumor associated antigen mimicry by xenoantigens, anti-idiotypic antibodies and peptide mimics: implications for immunotherapy of malignant diseases.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    DNA vaccines for melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Immunizing against partially defined antigen mixtures, gangliosides, or peptides to induce antibody, T cell, and clinical responses.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Chemotherapy, cytokines, and biochemotherapy for melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Current status of interferon-alpha in the treatment of melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    See all related articles

    Area of Science:

    • Oncology
    • Clinical Medicine
    • Cancer Research

    Background:

    • Ongoing debates surround the influence of alcohol, oral contraceptives, and hormone replacement therapy on breast cancer risk.
    • Research efforts are increasingly focused on achieving a cure for breast cancer.
    • Adjuvant systemic treatment is being considered for a broader range of primary breast cancer patients with curative potential.

    Purpose of the Study:

    • To review current clinical discussions and research directions in breast cancer management.
    • To evaluate the rationale and considerations for adjuvant therapy in primary breast cancer.
    • To highlight the challenges and current limitations in treating metastatic breast cancer.

    Main Methods:

    • Review of clinical discussions and research trends from 1989.

    Related Experiment Videos

  • Analysis of the justification for adjuvant systemic therapy in primary breast cancer.
  • Assessment of outcomes for intensive dose chemotherapy in metastatic disease.

    • Main Results:

    • The benefit of intensive dose chemotherapy for metastatic breast cancer has not been demonstrated.
    • Patients with primary tumors <1 cm and negative axillary nodes show high long-term recurrence-free survival (86% at 20 years).
    • Individualized patient assessment is crucial for weighing adjuvant therapy benefits and risks.

    Conclusions:

    • Further understanding of molecular and genetic factors is essential for future prevention and treatment strategies.
    • Adjuvant therapy decisions require careful consideration of individual patient prognosis, especially for those with early-stage disease.
    • Metastatic breast cancer remains largely incurable, and intensive chemotherapy has shown limited benefit.